Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Halpin, B. Celli, M. Decramer, S. Kesten, D. Liu, D. Tashkin (Exeter, United Kingdom; Boston, Ridgefield, Los Angeles, United States Of America; Leuven, Belgium). Risk of non-lower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial. Eur Respir J 2010; 36: Suppl. 54, 1191

Member's Comments

No comment yet.

Related content which might interest you: Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002 Safety of tiotropium in patients with cardiac events in the UPLIFT® trial Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Bacterial infections during acute exacerbations of COPD; a one-year prospective study Source: Eur Respir J 2001; 18: Suppl. 33, 183s Year: 2001 Predictors of frequent hospitalisations for exacerbations in COPD Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD Year: 2003 Adherence to medication, mortality and severe exacerbations in the TORCH study Source: Annual Congress 2008 - COPD Year: 2008 Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016 Impact of frailty during hospitalized exacerbations of COPD on 90-day readmissions - preliminary data. Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions Year: 2018 Cardiovascular risk assessment in COPD patients with severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Cardiovascular events (CVE) in COPD patients Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Factors associated with mortality in the TORCH trial in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 356s Year: 2007 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Predictive factors of 90-days post-discharge COPD acute exacerbation’s recurrence Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016